1. Home
  2. HAFC vs AURA Comparison

HAFC vs AURA Comparison

Compare HAFC & AURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Hanmi Financial Corporation

HAFC

Hanmi Financial Corporation

HOLD

Current Price

$32.14

Market Cap

972.5M

Sector

Finance

ML Signal

HOLD

Logo Aura Biosciences Inc.

AURA

Aura Biosciences Inc.

HOLD

Current Price

$6.91

Market Cap

797.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HAFC
AURA
Founded
1982
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
972.5M
797.5M
IPO Year
2000
2021

Fundamental Metrics

Financial Performance
Metric
HAFC
AURA
Price
$32.14
$6.91
Analyst Decision
Hold
Strong Buy
Analyst Count
3
5
Target Price
$32.17
$20.00
AVG Volume (30 Days)
161.3K
789.7K
Earning Date
04-21-2026
05-08-2026
Dividend Yield
3.75%
N/A
EPS Growth
22.44
N/A
EPS
1.54
N/A
Revenue
$270,165,000.00
N/A
Revenue This Year
$18.65
N/A
Revenue Next Year
$7.28
N/A
P/E Ratio
$20.73
N/A
Revenue Growth
15.28
N/A
52 Week Low
$22.85
$4.73
52 Week High
$33.50
$9.54

Technical Indicators

Market Signals
Indicator
HAFC
AURA
Relative Strength Index (RSI) 56.13 40.67
Support Level $31.44 $6.65
Resistance Level $32.70 $7.18
Average True Range (ATR) 0.49 0.31
MACD 0.10 -0.09
Stochastic Oscillator 87.23 8.37

Price Performance

Historical Comparison
HAFC
AURA

About HAFC Hanmi Financial Corporation

Hanmi Financial Corp is a Los Angeles-based bank that caters to Korean-Americans and other multi-ethnic communities across California, Colorado, Georgia, Illinois, New Jersey, New York, Texas, Virginia, and Washington. The bank mainly focuses on small businesses and commercial and real estate loans. It also offers a variety of international finance and trade services and products, including letters of credit, import financing, and export financing. The Bank's revenues are derived from interest and fees on loans, interest, and dividends on the securities portfolio, service charges on deposit accounts, and sales of SBA loans.

About AURA Aura Biosciences Inc.

Aura Biosciences Inc is a clinical-stage biotechnology company developing precision immunotherapies to treat a range of solid tumors designed to preserve the function of organs afflicted with cancer. Its candidate bel-sar is in late-stage clinical development for the treatment of patients with primary choroidal melanoma, and other ocular oncology indications as well as in early-stage clinical development in bladder cancer. The Company views its operations and manages its business in one operating segment operating exclusively in the United States.

Share on Social Networks: